Research In Cancer and Tumor

International Journal of Cancer and Tumor is a peer-reviewed international journal which provides a forum for prompt communication of original and innovative research findings that have relevance to understanding the etiology of cancer and to improving the treatment and survival of patients.

Andrea Padoan

Post-doctoral Fellow, Department of Medicine (DIMED), University of Padova, Italy

Research Areas

Biochemical markers, proteomics, genomics, statistical methods for biomarker discovery, pancreatic cancer, prostate cancer, laboratory quality assessment

Publications: Journals

[1]  BASSO D, BOZZATO D, PADOAN A, MOZ S, ZAMBON C-F, FOGAR P, GRECO E, SCORZETO M, SIMONATO F, NAVAGLIA F, FASSAN M, PELLOSO M, DUPONT S, PEDRAZZOLI S, FASSINA A, PLEBANI M.Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1.Cell Commun Signal.In press.Accepted for pubblication on March, 10th, 2014.IF: 5.09
[2]  GNATTA E, ZANINOTTO M, EPIFANI MG, PADOAN A, GJINI R, PLEBANI M. A new sampling device for faecal immunochemical testing: haemoglobin stability is still an open issue. Clin Chem Lab Med.2014; [Epub ahead of print].IF: 3.01
[3]  CAPOLUONGO E, ZAMBON CF, BASSO D, BOCCIA S, ROCCHETTI S, LEONCINI E, PALUMBO S, PADOAN A, ALBINO G, TODARO A, PRAYER-GALETTI T, ZATTONI F, ZUPPI C, PLEBANI M.PCA3 score of 20 could improve prostate cancer detection: Results obtained on 734 Italian individuals.Clin Chim Acta.2014; 429:46-50.IF: 2.85
[4]  AITA A, ROSSI E, BASSO D, GUARISO G, BOZZATO D, PELLOSO M, PESCARIN M, ZAMBON CF, NAVAGLIA F, GRECO E, GASPARETTO M, FOGAR P, PADOAN A, MOZ S, PLEBANI M.Chemiluminescence and ELISA-based serum assays for diagnosing and monitoring celiac disease in children: a comparative study.Clin Chim Acta.2013;421:202-7.IF: 2.85
[5]  PLEBANI M, SCIACOVELLI L, AITA A, PADOAN A, CHIOZZA ML.Quality indicators to detect pre-analytical errors in laboratory testing.Clin Chim Acta.2013; S0009-8981(13)00336-7.IF: 2.85
[6]  BASSO D, FOGAR P, FALCONI M, FADI E, SPERTI C, FRASSON C, GRECO E, TAMBURRINO D, TEOLATO S, MOZ S, BOZZATO D, PELLOSO M, PADOAN A, DE FRANCHIS G, GNATTA E, FACCO M, ZAMBON CF, NAVAGLIA F, PASQUALI C, BASSO G, SEMENZATO G, PEDRAZZOLI S, PEDERZOLI P, PLEBANI M.Pancreatic Tumors and Immature Immunosuppressive Myeloid Cells in Blood and Spleen: Role of Inhibitory Co-Stimulatory Molecules PDL1 and CTLA4.An In Vivo and In Vitro Study.PLoS One.2013; 8(1).Epub 2013.IF: 4.09
[7]  PADOAN A, SERAGLIA R, BASSO D, FOGAR P, SPERTI C, MOZ S, GRECO E, MARCHET A, DE MANZONI G, ZAMBON CF, NAVAGLIA F, CRISTADORO L, DI CHIARA A, NITTI D, PEDRAZZOLI S, PAVANELLO G, PLEBANI M.Usefulness of MALDI-TOF/MS Identification of Low-MW Fragments in Sera for the Differential Diagnosis of Pancreatic Cancer.Pancreas.2013.42(4):622-32.IF: 2.95.
[8]  ZANINOTTO M, TASINATO A, PADOAN A, VECCHIATO G, PINATO A, SCIACOVELLI L, PLEBANI M.Effects of sample transportation on commonly requested laboratory tests.Clin Chem Lab Med.2012; 50(10):1755-60.IF: 3.01
[9]  ZANINOTTO M, TASINATO A, PADOAN A, VECCHIATO G, PINATO A, SCIACOVELLI L, PLEBANI M.An integrated system for monitoring the quality of sample transportation.Clin Biochem.2012; 45(9):688-90.IF: 2.45
[10]  CARTEI G, CARTEI F, BERTIN M, PADOAN A, ZUSTOVICH F, NICOLETTO MO, PLEBANI M.CA125 reference values change in male and postmenopausal female subjects.Clin Chem Lab Med.2012; 0(0):1.IF: 3.01
[11]  ZAMBON CF, PRAYER-GALETTI T, BASSO D, PADOAN A, ROSSI E, SECCO S, PELLOSO M, FOGAR P, NAVAGLIA F, MOZ S, ZATTONI F, PLEBANI M.Effectiveness of the combined evaluation of KLK3 genetics and free-to-total prostate specific antigen ratio for prostate cancer diagnosis.J Urol.2012; 188(4):1124.IF: 3.75
[12]  SCIACOVELLI L, SONNTAG O, PADOAN A, ZAMBON CF, CARRARO P, PLEBANI M.Monitoring quality indicators in laboratory medicine does not automatically result in quality improvement.Clin Chem Lab Med.2011; 50(3):463-9.IF: 2.15
[13]  BERNARDI D, PADOAN A, BALLIN A, SARTORI M, MANARA R, SCIENZA R, PLEBANI M, DELLA PUPPA A.Serum YKL-40 following resection for cerebral glioblastoma.J Neurooncol.2012; 107(2):299-305.IF: 3.21
[14]  FOGAR P, BASSO D, FADI E, GRECO E, PANTANO G, PADOAN A, BOZZATO D, FACCO M, SANZARI MC, TEOLATO S, ZAMBON CF, NAVAGLIA F, SEMENZATO G, PEDRAZZOLI S, PLEBANI M.Pancreatic cancer alters human CD4+ T lymphocyte function: a piece in the immune evasion puzzle.Pancreas.2011; 40(7):1131.IF: 2.38
[15]  BASSO D, GUARISO G, BOZZATO D, ROSSI E, PESCARIN M, FOGAR P, MOZ S, NAVAGLIA F, PELLOSO M, GASPARETTO M, ZAMBON CF, PADOAN A, GRECO E, RUGGE M, PLEBANI M.New screening tests enrich anti-transglutaminase results and support a highly sensitive two-test based strategy for celiac disease diagnosis.Clin Chim Acta.2011; 412(17-18):1662-7.IF: 2.53
[16]  FLOREANI A, NAVAGLIA F, RIZZOTTO ER, BASSO D, CHIARAMONTE M, PADOAN A, PETRIDIS I, CAZZAGON N, TESTA R, MARRA M, PLEBANI M.Mass spectrometry measurement of plasma hepcidin for the prediction of iron overload.Clin Chem Lab Med.2011; 49(2):197-206.IF: 2.15
[17]  SARTORI MT, DELLA PUPPA A, BALLIN A, SAGGIORATO G, BERNARDI D, PADOAN A, SCIENZA R, D'AVELLA D, CELLA G.Prothrombotic state in glioblastoma multiforme: an evaluation of the procoagulant activity of circulating microparticles.J Neurooncol.2011; 107(2):299-305.IF: 2.93
[18]  BASSO D, GRECO E, PADOAN A, FOGAR P, SCORZETO M, FADI E, BOZZATO D, MOZ S, NAVAGLIA F, ZAMBON CF, SERAGLIA R, CARLO ED, VALERIO A, REGGIANI C, PEDRAZZOLI S, PLEBANI M.Altered intracellular calcium fluxes in pancreatic cancer induced diabetes mellitus: Relevance of the S100A8 N-terminal peptide (NT-S100A8).J Cell Physiol.2011; 226(2):456-68.IF: 3.87
[19]  PADOAN A, FOGAR P, GRECO E, FADI E, BOZZATO D, MOZ S, NAVAGLIA F, ZAMBON C-F, SERAGLIA R, PELLOSO M, ROSSI E, BASSO D, PLEBANI M.Identificazione di potenziali biomarcatori sierici di adenocarcinoma pancreatico.Biochimica Clinica.2011; 35(4):280.(Article in italian).
[20]  FOGAR P, NAVAGLIA F, BASSO D, ZAMBON CF, MOSERLE L, INDRACCOLO S, STRANGES A, GRECO E, FADI E, PADOAN A, PANTANO G, SANZARI MC, PEDRAZZOLI S, MONTECUCCO C, PLEBANI M.Heat-induced transcription of diphtheria toxin A or its variants, CRM176 and CRM197: implications for pancreatic cancer gene therapy.Cancer Gene Theraphy.2010; 17(1):58-68.IF: 3.74
[21]  GRECO E, BASSO D, FADI E, PADOAN A, FOGAR P, ZAMBON CF, NAVAGLIA F, BOZZATO D, MOZ S, PEDRAZZOLI S, PLEBANI M.Analogs of vitamin E epitomized by alpha-tocopheryl succinate for pancreatic cancer treatment: in vitro results induce caution for in vivo applications.Pancreas.2010; 39(5):662-8.IF: 2.60
[22]  NAVAGLIA F, FOGAR P, BASSO D, GRECO E, PADOAN A, TONIDANDEL L, FADI E, ZAMBON CF, BOZZATO D, MOZ S, SERAGLIA R, PEDRAZZOLI S, PLEBANI M.Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.Clin Chem Lab Med.2009; 47(6):713-23.IF: 1.89
[23]  ZAMBON C-F, FASOLO M, BASSO D, D’ODORICO A, STRANGES A, NAVAGLIA F, FOGAR P, GRECO E, SCHIAVON S, PADOAN A, FADI E, STURNIOLO G C, PLEBANI M, PEDRAZZOLI S.Clarithromycin resistance, tumor necrosis factor alpha gene polymorphism and mucosal inflammation affect H.pylori eradication success.J Gastrointest Surg.2007; 11(11):1506-14.IF: 2.27
[24]  BASSO D, NAVAGLIA F, FOGAR P, ZAMBON C-F, GRECO E, SCHIAVON S, FASOLO M, STRANGES A, FALDA A, PADOAN A, FADI E, PEDRAZZOLI S, PLEBANI M.DNA repair pathways an mitochondrial DNA mutations in gastrointestinal carcinogenesis.Clin Chim Acta.2007; 381(1):50-5.IF: 2.6

Publications: Conferences/Workshops/Symposiums

[1]  PADOAN A, LA MALFA M, BASSO D, ZAMBON C.F, MOZ S, BOZZATO D, FOGAR P, GRECO E, NAVAGLIA F, PAVANELLO G, PLEBANI M.Prostate cancer urine protein profiling by MALDI-TOF/MS: normalization, reproducibility and preliminary results.Euromedlab Conference.May 2013, Milan, Italy.
[2]  AITA A, BASSO D, ROSSI E, PELLOSO M, GUARISO G, ZAMBON C.F, NAVAGLIA F, GRECO E, BOZZATO D, PADOAN A, FOGAR P, PLEBANI M.Celiac disease diagnosis and monitoring: comparison between chemiluminescence and ELISA antitransglutaminase and anti-deamidated gliadin peptides measurements.Euromedlab Conference.May 2013, Milan, Italy.
[3]  ROSSI E., ZAMBON C.F, NAVAGLIA F, GRECO E, BOZZATO D, PELLOSO M, PADOAN A, AITA A, FOGAR P, MOZ S, GNATTA E, TESSARI A, GUARISO G, BASSO D, PLEBANI M.Tumor necrosis factor alpha (TNFα) promoter haplotype concurs with HLA-DQA1-DQB1 in determine celiac disease risk.Euromedlab Conference.May 2013, Milan, Italy.
[4]  SCIACOVELLI L, PADOAN A, AITA A, PLEBANI M.IFCC project “Model of quality indicators”: a method for results evaluation.Euromedlab Conference.May 2013, Milan, Italy.
[5]  MOZ S, BOZZATO D, PADOAN A, ZAMBON C.F, FOGAR P, SPERTI C, GRECO E, NAVAGLIA F, PELLOSO M, ROSSI E, PASQUALI C, PLEBANI M, BASSO D.Hyperglycemia-induced S100A8 and S100A9 expression target ATK, mTOR and NF-KB signalling in pancreatic cancer cells.Euromedlab Conference.May 2013, Milan, Italy.
[6]  GNATTA E, FOGAR P, AITA A, FRASSON C, TEOLATO S, FACCO M, BOZZATO D, GRECO E, PADOAN A, NAVAGLIA F, MOZ S, ZAMBON C.F, SEMENZATO G, BASSO G, PLEBANI M, BASSO D.Pancreatic cancer-derived soluble mediators induce dendritic cells to acquire an immunosuppressive phenotype by downregulating CTLA4.Euromedlab Conference.May 2013, Milan, Italy
[7]  BOZZATO D, SIMONATO F, MOZ S, FASSAN M, FOGAR P, PADOAN A, FASSINA A, PEDRAZZOLI S, PLEBANI M, BASSO D.The inflammatory molecules S100A8 and TGF-b1 activate the epithelial-mesenchymal transition (EMT) process in pancreatic cancer (PaCa) cells.Euromedlab Conference.May 2013, Milan, Italy.
[8]  BOZZATO D, MOZ S, PADOAN A, SCORZETO M, FOGAR P, SPERTI C, GRECO E, ZAMBON C.F, NAVAGLIA F, PELLOSO M, ROSSI E, PASQUALI C, REGGIANI C, PLEBANI M, BASSO D.The inflammatory calcium binding protein S100A8 and its n-terminal proteolytic fragment interact with transforming growth factor-beta1 (TGF-b1) and alter AKT, mTOR and NF-KB cancer cell signaling.Euromedlab Conference.May 2013, Milan, Italy
[9]  BASSO D, ZAMBON C-F, PADOAN A, PRAYER-GALETTI T, SECCO S, ZATTONI F, PLEBANI M.PCA3 and prostate health index (PHI) do not challenge f/t PSA in prostate cancer (PCA) diagnosis.Euromedlab Conference.May 2013, Milan, Italy.
[10]  BOZZATO D, MOZ S, GRECO E, NAVAGLIA F, PADOAN A, PLEBANI M, BASSO D.SMAD4 Deletion and EGF co-operate in favoring mTOR Activation in PDAC Cells.37th Italian Association for the Study of Pancreas Conference.September 2013, Bologna, Italy.
[11]  MOZ S, BOZZATO D, ZAMBON C-F, FOGAR P, PELLOSO M, MILANETTO A-C, PADOAN A, NAVAGLIA F, GRECO E, PASQUALI C, PLEBANI M, BASSO D.MMP9 and S100A9 Expression in Peripheral Blood Mononuclear Cells (PBMC) are correlated with Pancreatic Adenocarcinoma (PDAC) and with PDAC-Associated Diabetes Mellitus.37th Italian Association for the Study of Pancreas Conference.September 2013, Bologna, Italy.
[12]  PADOAN A, LA MALFA A, BASSO D, AIYETAN P, PAVANELLO G, BELLOCCO R, ZHANG H, CHAN D.W., PLEBANI M.Reproducibility in Urine Proteomic Profilino by MALDI-TOF/MS.US HUPO 9th Annual Conference.March 2013, Baltimore, MD.